Invisicare® releases more drug to and through the skin, says Ovation Science Inc. (CSE:OVAT) Director Doreen McMorran
In this interview from the New Green Frontier Cannabis Investor Conference presented by SmallCapPower and Capital Ideas TV, Doreen McMorran, Co-Founder and Director of Ovation Science Inc. (CSE:OVAT), talks about the Company’s patented topical and transdermal delivery system called Invisicare®. Ovation Science has already licensed its Invisicare® skin delivery technology in both Canada and the United States.
Ubika Research/SmallCapPower has received compensation from Ovation Science Inc. to provide analyst research coverage. For full disclosure please visit here >>
To read our full disclosure, please click on the button below: